Pharmafile Logo
Pharmafocus logo
Advanced Search

life sciences

Showing 15 posts of 99 posts found.

brain-1787622_640

Early-stage study gives hope for rare and fatal neurodegenerative condition

August 11, 2017
Medical Communications, Research and Development biotech, drugs, healthcare, life sciences, medicine, pharma, pharmaceutical

A team of researchers at Washington University School of Medicine (WUSM) in St Louis and the Eunice Kennedy Shriver National …

News
shutterstock_87495637

Ending the era of $100,000 cancer drugs

August 11, 2017
Medical Communications, Research and Development Cancer, biotech, drugs, healthcare, immunotherapy, life sciences, medicine, pharma, pharmaceutical

Paul Workman, Chief Executive and President of the Institute of Cancer Research, examines the spiralling cost of cancer treatments and …

News
heart-2372134_640

Heart failure mortality rates fall across England and Wales, national audit finds

August 11, 2017
Medical Communications, Research and Development cardiovascular, heart, heart disease, life sciences, pharma, pharmaceutical

Great news in the cardiovascular space as results from the National Heart Failure Audit indicate that better treatment has led …

News
continuous_manufacturing2

Continuous manufacturing: Upgrading the supply chain to meet rising demand

August 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing continuous manufacturing, life sciences, manufacturing, medicine, pharma, pharmaceutical

Pharmaceutical production has long been the object of scrutiny to ensure the highest levels of quality and safety are maintained. …

Feature
shutterstock_138095450

Japanese telecom giant injects $1.1bn into Swiss biotech in largest-ever investment of its kind

August 10, 2017
Sales and Marketing Roivant, SoftBank, biotech, life sciences, medicine, pharma, pharmaceuticals

In possibly the biggest single biotech investment ever made, Swiss biotech firm Roivant has received a $1.1 billion cash injection …

News

Bayer’s liver cancer drug availability spreads to UK with NICE approval

August 10, 2017
Sales and Marketing Bayer, Cancer, NICE, Nexavar, life sciences, liver cancer, pharma, pharmaceutical

NICE has announced that it has given final appraisal recommending Bayer’s Nexavar (sorafenib) for the treatment of advanced hepatocellular carcinoma …

News
bribe

One in twelve US doctors accepted opioid-related payments from pharma, finds study

August 10, 2017
Medical Communications, Sales and Marketing US, bribe, drugs, life sciences, medicine, opioids, pharma, pharmaceutical

In the first large-scale study of its kind, a team of researchers at Boston Medical Center’s Grayken Center for Addiction …

News
cancer-vs-alzheimer-1080x810

Cancer Research UK partners with Biotecnol to deliver experimental solid tumour drug

August 10, 2017
Research and Development, Sales and Marketing Biotecnol, Cancer, Cancer Research UK, drugs, immunotherapy, life sciences, medicine, pharma, pharmaceutical

Cancer Research UK (CRUK) has announced a collaboration with Biotecnol, an immuno-oncology firm focused on the development of multifunctional antibodies …

News

Pioneering immunotherapy halts progression of type 1 diabetes

August 10, 2017
Research and Development Type 1 diabetes, diabetes, drugs, insulin, life sciences, medicines, pharma, pharmaceutical

In a first for the disease area, an immunotherapy treatment for diabetes, developed by researchers at King’s College London and …

News
shutterstock_38078521

FDA awards orphan status to new brain cancer vaccine

August 9, 2017
Research and Development, Sales and Marketing FDA, life sciences, orphan drug, pharma, pharmaceuticals

The FDA has announced that it has awarded orphan drug status to the vaccine SurVaxM for patients with glioblastoma, the …

News
800px-cancer_cells_1

Chemotherapy can spread breast cancer to lungs, study finds

August 9, 2017
Research and Development Cancer, breast cancer, life sciences, lung cancer, pharma, pharmaceutical

Researchers at Ohio State University have discovered that, as well as forming a key part of treatment strategies to fight …

News

Merck scores expanded NICE recommendation in head, neck and oral cancer

August 8, 2017
Manufacturing and Production, Sales and Marketing Erbitux, Merck, NICE, biotech, cetuximah, drugs, life sciences, pharma, pharmaceuticals

Merck has announced its approval of NICE’s decision to expand its recommendation of Erbitux (cetuximab) to include its use as …

News
nice_new_london_office_internal_3_web

NICE recommends plaque psoriasis contender for NHS use

August 8, 2017
Manufacturing and Production, Sales and Marketing Almirall, NICE< Skilarence, drugs, life sciences, medicine, pharma, pharmaceuticals, plaque psoriasis, psoriasis

The use of Almirall’s psoriasis drug Skilarence (dimethyl fumarate) on the UK’s NHS is one step closer after NICE gave …

News
shutterstock_311949818

Stomach acid drugs do not increase Alzheimer’s risk, study confirms

August 7, 2017
Research and Development, Sales and Marketing Alzheimer's, dementia, drugs, healthcare, lansoprazole, life sciences, medicine, omeprazole, pharma, pharmaceuticals, proton pump inhibitors

A new study from the University of Eastern Finland has indicated that the use of proton pump inhibitors such as …

News
fda2outsideweb

FDA fast tracks Valneva’s Lyme disease vaccine

August 7, 2017
Research and Development, Sales and Marketing Valneva, biotech, life sciences, lyme disease, medicines, pharma, pharmaceutcial

French firm Valneva has announced that its Lyme disease vaccine, known at this stage only by VLA15, has been fast-tracked …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026